Abstract: Data on 11,977 insertions of an intrauterine device (IUD) from 25 collaborating centers in 16 less developed countries (LDCs) were investigated for IUD-associated hospitalizations. These centers maintained regular follow-up and reported at least one hospitalization among their IUD cases. The Lippes Loop, Copper T, Delta Loop, and Delta T were the most commonly used devices, and three-fourths of all devices were inserted in postpartum women. Fifty-five of the 128 reported subsequent hospitalizations were associated with IUD use. Main indications for IUD-associated hospitalizations were pelvic infection, bleeding/pain, and method
Introduction
Eleven million women in developed countries (DCs) and six million women in less developed countries (LDCs) are presently estimated* to be using the intrauterine contraceptive device (IUD). I Rare but serious complications associated with IUD use do occur in some women and carefully conducted studies on IUD safety are needed, especially for developing countries. 2 Recognizing the enormous practical and logistical problems in implementing a prospective study for this purpose, the authors utilized an existing international data set coordinated by Family Health International (FHI)** to estimate the magnitude as well as ascertain the nature of those events that led to IUD-associated hospitalizations.
Two reports on IUD-associated hospitalizations of women in the United States are presently available.3,4 The study reported here will be the first on such hospitalizations for LDC women, who differ from their Western counterparts in many aspects, including availability and accessibility of hospital care. No claim is intended that the findings here are representative of the developing world, since our data are not proportionally distributed among LDCs according to the size of the population or by the number of IUD users for each of the LDCs.
Materials and Methods
Seventy-six centers in 31 countries contributed data on 22,181 IUD insertions from March 1976 to December 1981. Pertinent information on patient characteristics and medical conditions at the time of IUD insertion was recorded on a standard admission form. Data on any hospitalization following insertion, including the date hospitalized, the primary reason for hospitalization, and the duration of the hospitalization in number of completed days, were entered on the follow-up record. Follow-up schedules were similar among centers, generally planned for postinsertion; for postpartum studies, however, several centers followed their cases for only six months after IUD insertion.
A total of 56 centers with systematic follow-up in 22 countries categorized as LDCs*** contributed data on 17,121 IUD users. Due to the concern that if a center did not report at least one hospitalization for any reason their reporting might be unreliable, most of our analyses are confined to the 25 centers from which at least one hospitalization was reported. On the average, the number of insertions in these 25 centers was three times as high as that in those 31 centers which did not report a hospitalization. Among centers reporting at least one hospitalization, however, we did not detect an association between hospitalization rates and number of insertions.
The cut-off date for this analysis was July 30, 1982, seven months after the last IUD insertion. This population comprised 11 aReasons include persistent vomiting for two months post-IUD insertion, IUD expulsion (10 days post-insertion) and post-cesarean infection (IUD inserted six days after cesarean, onset of infection unknown).
bReasons include typhoid (3) and one case each of measles, arthrosis, colic, sacrohypogastric pain, platelet disorder, depression, pneumonia, cold, fever, cardiopathy, epilepsy and tuberculosis (12) .
CReasons include voluntary sterilization (7) , cholecystectomy (5), appendectomy (2), and one case each of ovarian cyst, hemiated vertebral disc, and what was described as a iatrogenic lesion of the cecum encountered at the tme of cesarean section (3).
dReasons include curettage (6), dehiscience of the episiotomy (6), postpartum endometritis associated with retained products (5), puerperal bleeding (6), metrorrhagia (3), perineotomy (3), and puerperal distension (1).
*Reasons include mastitis (3), bartholinitis (2), conization (2), and one case each of trichomoniasis, leukorrhea, salpingectomy and hysterectomy for uterine prolapse (4). in cases considered closed by FHI protocol (e.g., after pregnancy, expulsion, or removal) were not available. Hospitalization for women following an interval or postabortion insertion is a clear-cut event. For women who delivered in the hospital with a subsequent postpartum insertion while still hospitalized (62.6 per cent inserted immediately after delivery), hospitalization is defined as either a separate hospitalization after discharge from the hospital for delivery or the same hospitalization for delivery prolonged due to IUD-associated problems.
A total of 128 hospitalizations were delineated from the data set of the LDC women and were categorized by the authors as IUD-associated or non-IUD-associated. Categorization of hospitalization was done blind to the type of center. Pelvic infection, bleeding, sepsis, uterine perforation, or instances where the IUD could not be excluded as a causative factor were classified as IUD-associated.
Using the same data set, indications for hospitalization, IUD-associated or non-IUD-associated, for LDC women were compared with those for DC women. Three-month cumulative gross life table rates were used to examine the effects of age, parity, timing of insertion in relation to termination of last pregnancy, IUD type, and category of inserting personnel on IUD-associated hospitalizations. The overall three-month follow-up rate was satisfactorily high (76 per cent, after excluding from the denominator those previously terminated due to pertinent events). Seventy-eight per cent of all IUD-associated hospitalizations occurred within three months of insertion. Unadjusted and adjusted rates by Herson's standardization method" were calculated. * Method failure-related hospitalizations were examined separately.
Results
As shown in Table 2 , pelvic infection, bleeding/pain, and method failure were the three main reasons for IUDassociated hospitalization for both LDC and DC women. Only one hospitalization in both groups was attributable to uterine perforation. The LDC case was detected six weeks after insertion of a Tapered Lippes Loop. None of the hospitalized method failures were due to an ectopic pregnancy.
*For instance, hospitalization rates by timing of insertion were controlled for both age and parity. Two-thirds of the hospitalizations associated with IUDrelated complications were reported within the first month and 78 per cent within the first three months after insertion. This is especially true for the postpartum insertions. ** Ninety-one per cent of the postpartum hospitalizations occurred by the time of the first follow-up visit. Forty-six of all devices in women with IUD-associated hospitalizations had been removed by the time of hospital discharge.
The number of hospitalizations not associated with IUD use surpassed the IUD-associated hospitalizations for IUD users in LDCs, while for IUD users in DCs, one-third of the hospitalizations were unrelated to IUD use.
IUD-Associated Hospitalization Rates
Two crude rates were calculated: a lower estimate of 3.2 per 1,000 insertions using the 17,121 cases from the LDC centers with systematic follow-up as the denominator, and a higher estimate of 4.6 using the 11,977 cases from centers with systematic follow-up which reported at least one hospitalization as the denominator. Six-month and one-year net cumulative life table hospitalization rates were also calculated using our study population (11, 977) as the denominator. These rates were 4.3/1,000 and 6.3/1,000 insertions, respectively. The Pearl rate was estimated as 8.0/1,000 womanyears of IUD use. Rates are very similar to those in DCs (Table 3) . Table 4 shows that the three-month cumulative gross life table rate for hospitalization due to IUD complications was higher in women less than 30 years of age, in parity 0-1 women, and in women with postpartum insertions.
Method Failure-Related Hospitalizations
Relevant information on the 15 method failures requiring hospitalization reported among the LDCs is presented in Table 5 . All conceptions occurred after insertion of an IUD and were diagnosed prior to device expulsion or device removal. When these pregnancies were classified by timing "*This may be due in part to the practical difficulties in separating IUDrelated from delivery-related complications.
of IUD insertion, five induced abortions and one spontaneous abortion followed the six interval insertions, one induced abortion followed a post-abortion insertion, and spontaneous abortion ended all eight pregnancies among the postpartum insertions. Six (40 per cent) of these pregnancies occurred within six months of IUD insertion and 13 (86.7 per cent) within the first year of use, as calculated from the reported onset of the last menstrual period.
The five pregnancies occurring in users of the TR-11*** were reported from a Middle East center. All were terminated by induced abortion. In three cases, the TR-l ls were found to be displaced at the time of termination. The total number of insertions with this experimental device was 204 in our study population and 121 in this center, producing very high crude rates of 24.5 and 41.3, respectively, per 1,000 TR-II insertions for method-failure hospitalizations.
One death was reported for an Indonesian woman with a Delta Loop insertion immediately after a cesarean section delivery. The women died three days after delivery; thromboembolism was the reported cause of death. No autopsy was performed. The investigator thought the death was related to the surgery and not the IUD.
Discussion
The data set we used for this study is unique in the following respects: * It was coordinated by one agency (FHI) and all the international centers were using the same record forms and were following a similar protocol, thus we have a well-defined study population with regular follow-up; * The characteristics of the IUD users, findings from medical examination, as well as the type of IUD used
were all recorded at the time of insertion and did not require the women's recollection of those events at the time of hospitalization; ***An experimental T-shaped device, it is small in size, with a half round section on the transverse arm to minimize embedding and a reduced length to decrease the risk of perforation. * Information related to the hospitalization was reported by the attending physicians at the time of hospitalization or reported by the patient at the subsequent follow-up rather than obtained from a later survey that depended on the physician's recollection or search for medical charts. Our main concern was underreporting of hospitalizations, especially since the data are primarily from LDCs.
All LDC centers in this study were hospitals, which theoretically should be in a more advantageous position than freestanding clinics to admit patients, and to be informed about, as well as to report, hospitalization of their IUD clients. While the IUD-associated hospitalization rates (crude rates, life table rates, or Pearl rates) were similar in LDC and DC users, the non-IUD-associated rate was higher for the LDC users. This may be due in part to the generally higher overall morbidity rate in LDCs as well as the fact that four of the 11 DC centers were clinics for which no non-IUDrelated hospitalizations would have been reported. While these findings are not conclusive, they are not inconsistent with the assumption that our hospitalization data as a whole are of acceptable quality. The conspicuous absence of hospitalizations due to ectopic pregnancyt and the single hospitalization reportedly due to uterine perforation (in contrast to 19 per cent from the CDC report),3 however, strongly suggest underreporting in our data set.
It is also possible that these IUD-associated hospitalizations are overreported, since some of these categorized hospitalizations may represent a coincidental incidence of pelvic inflammation or bleeding actually unrelated to IUD *Three ectopic pregnancies were reported among the 217 accidental pregnancies from the LDC data, one was reported among 61 unplanned pregnancies from the DC data; hospitalization information for these ectopic pregnancies was not recorded. use, especially for those women with an IUD inserted immediately postpartum in the hospital.
One agreement between these findings on LDC women and the findings from the CDC report on US women3 was that pelvic infection was the primary cause of IUD-associated hospitalizations. Bleeding, the second indication in our data, was the fourth indication in the CDC report.
The somewhat higher hospitalization rate due to IUD complications found in younger and 0-1 parity women seems commensurate with the higher removal rate for pain and bleeding in these groups of women as shown in the Cooperative Statistical Program (CSP) study.'2 Difficulties in separating IUD-related complications from delivery-related complications for women with immediate postpartum insertion might have contributed to the somewhat higher hospitalization rate over women with interval insertions. Also, the definitions used in this study allow women with immediate postpartum insertion to be classified more easily as a hospitalization case than women with interval insertions.
Due to the limitations of our data, the significance of the difference in outcomes for the accidental pregnancies in the interval and postpartum insertions as well as the risks of an IUD user's pregnancy being ectopic or terminated in septic abortion could not be addressed. The outcomes using the experimental TR-11, as compared to commonly used devices, could reflect a higher failure rate, a higher complication rate, or simply a center-specific policy of hospitalization for cases with method failure.
In assessing the life table rates and other calculations, six-and twelve-month follow-up rates are low. We feel, however, that our rates did not overestimate the actual incidence of IUD-associated hospitalizations in LDCs.
Although the IUD-associated hospitalizations reported here were rare, they deserve particular attention in LDCs where medical manpower and resources are scarce. Since these data reflect only a portion of all complications, the true magnitude of this problem will remain unknown until national programs of postmarketing surveillance of IUDs are implemented. 13
